Pain Management for Nail Diseases

This trial aims to determine which pain relief method works best after nail surgery. Participants will receive one of three treatments: suzetrigine (a new potential drug), a combination of oxycodone and acetaminophen, or alternating doses of acetaminophen and ibuprofen. The trial seeks individuals undergoing a nail procedure at Dr. Brian Morrison's clinic who can understand English or Spanish. Those needing pain management options after nail surgery might find this trial suitable. As a Phase 4 trial, the treatments are already FDA-approved and proven effective, providing an opportunity to benefit from established pain relief methods.

A previous study found suzetrigine to be safe and effective for managing post-surgical pain. The FDA has approved it for this use, indicating it has undergone testing and is generally safe. Reports show that over a million prescriptions have been filled, suggesting it is well-tolerated by many patients.

Oxycodone and acetaminophen are common pain relievers. Oxycodone, an opioid, can cause side effects like drowsiness or dizziness but is often used for post-surgical pain. Acetaminophen is also widely used and gentle on the stomach.

Alternating between acetaminophen and ibuprofen is another common pain relief method. Both are available over the counter and are generally well-tolerated. Acetaminophen is easy on the stomach, while ibuprofen reduces swelling due to its anti-inflammatory properties.

Suzetrigine is unique because it offers a new way to manage post-operative pain specifically for nail diseases. Unlike traditional options like acetaminophen/ibuprofen or oxycodone combined with acetaminophen, suzetrigine may work through a novel mechanism that researchers are eager to explore. This investigational treatment could provide effective pain relief with potentially fewer side effects, making it an exciting option for both patients and healthcare providers.

This trial will compare different pain management strategies for nail diseases. Studies have shown that suzetrigine, administered to participants in the Suzetrigine Group, effectively manages post-surgery pain. It has enabled 76.1% of patients to recover without needing additional pain relief, avoiding opioids. Suzetrigine acts quickly and provides pain relief comparable to common opioid treatments like hydrocodone/acetaminophen. Participants in the Oxycodone + Acetaminophen Combination Group will receive this well-known option, which effectively relieves moderate to severe pain. Meanwhile, the Alternating Acetaminophen/Ibuprofen Group will receive a non-opioid choice that has managed pain well, offering fewer side effects. Each of these treatments has proven reliable for managing pain, especially after surgery.⁶⁷⁸⁹¹⁰